EST BioXcel Therapeutics (BTAI) trading halted, news pendingMaximize Your Portfolio with Data Driven Insights:Leverage the power of ...

EST Pliant Therapeutics (PLRX) trading resumesMaximize Your Portfolio with Data Driven Insights:Leverage the power of TipRanks' Smart ...

Iterum Therapeutics (ITRM) has disclosed a new risk, in the Sales & Marketing category. Iterum Therapeutics faces a significant business risk as ...

B. Riley lowered the firm’s price target on Viking Therapeutics (VKTX) to $96 from $109 and keeps a Buy rating on the shares.

Revance Therapeutics ( ($RVNC) ) has issued an update. On February 6, 2025, Revance Therapeutics finalized a merger with Crown Laboratories, ...

The FDA will allow two biotechnology companies to run clinical trials: United Therapeutics and eGenesis. United Therapeutics ...

Cantor Fitzgerald raised the firm’s price target on PTC Therapeutics (PTCT) to $113 from $76 and keeps an Overweight rating ...

As we observe World Cancer Day today, let us look at some of the trends in cancer therapeutics expected to improve cancer ...

Following the approval of the Biotechnology for Economy, Environment and Employment (BioE3) by the Union Cabinet last August, ...

A microbioreactor is a way of “doing more with less” succinctly stated Wei-Xiang Sin, PhD, research scientist at SMART CAMP. As these tiny growth machines become even more sophisticated with machine ...

Prime Medicine, Inc. faces risks in the gene editing sector despite positive developments, caution advised for retail investors. Click for my PRME stock update.